In its Nov. 26 legislative update, "What's Racing Through Washington," the NTRA noted that there has been progress for legislation that would restore the ability of taxpayers with gambling winnings to claim 100% of their losses against the winnings ... .
Genetic testing company Natera (NASDAQ. NTRA) ... Is now the time to buy NTRA? Find out in our full research report (it’s free for active Edge members). Natera (NTRA) Q3 CY2025 Highlights..Revenue ... $27.24 billion. StockStory’s Take ... Gross margin improvement ... .
NTRA) ... Natera (NTRA) Q3 CY2025 Highlights..Revenue ... $27.44 billion ... NTRA) develops and commercializes genetic tests for prenatal screening, cancer detection, and organ transplant monitoring using its proprietary cell-free DNA technology.Revenue Growth ... .
Genetic testing company Natera (NASDAQ. NTRA). will be reporting earnings this Thursday after the bell. Here’s what to expect. Natera beat analysts’ revenue expectations by 14.7% last quarter, reporting revenues of $546.6 million, up 32.2% year on year ... .